1. Academic Validation
  2. CYFIP2, a direct p53 target, is leptomycin-B sensitive

CYFIP2, a direct p53 target, is leptomycin-B sensitive

  • Cell Cycle. 2007 Jan 1;6(1):95-103. doi: 10.4161/cc.6.1.3665.
Roger S Jackson 2nd 1 Yong-Jig Cho Susanne Stein Peng Liang
Affiliations

Affiliation

  • 1 Vanderbilt-Ingram Comprehensive Cancer Center, Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6840, USA.
Abstract

A number of target genes for the tumor suppressor, p53, have been identified, however, the mechanisms that contribute to p53-dependent Apoptosis remain to be fully elucidated. In a comprehensive screen for p53 target genes, we have identified Cytoplasmic FMR Interacting Protein 2 (CYFIP2) as a p53-inducible gene. Here we show that the CYFIP2 promoter contains a p53-responsive element that confers p53 binding as well as transcriptional activation of a heterologous reporter. Inducible expression of CYFIP2 is sufficient for Caspase activation and cellular Apoptosis, reminiscent of p53 activation. Together, these results suggest that CYFIP2 is a direct p53 target gene that may be part of a redundant network of genes responsible for p53-dependent Apoptosis. In addition, the sensitivity of CYFIP2 protein subcellular localization to Leptomycin-B, a CRM-1/Exportin inhibitor, suggests that the biological functions of CYFIP2 may extend from the cytoplasmic compartment into the nucleus of the cell.

Figures